Design Therapeutics, Inc.: Wells Fargo initiates coverage with overweight rating
DSGN•Wells Fargo initiated coverage of Design Therapeutics with an overweight rating.
Related News
Liquidia Corporation: Wells Fargo cuts target price to $30 from $108
LQDA•
McCormick: Deutsche Bank cuts target price to $57 from $59
MKC•
Kite Realty Group Trust: Truist Securities initiates coverage with hold rating; price target $27
KRG•
Nike: Morgan Stanley cuts target price to $27 from $31
NKE•
PLDT completes purchase of remaining 65.1% stake in Radius Telecoms
PHI•